20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Scholar Rock Holding Corp (SRRK) operates in the BIOTECHNOLOGY industry and is headquartered in Cambridge, United States with about 289 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, SRRK reported $0M in revenue and ($378M) in net income.
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $33M | $19M | $15M | $20M | $0M | $0M | $0M |
| Gross Profit | — | ($208M) | ($2M) | ($3M) | $33M | ($90M) | $15M | $20M | ($36M) | ($1M) | ($12M) |
| Gross Margin % | — | — | — | — | 100.0% | -476.5% | 100.0% | 100.0% | — | — | -3192.1% |
| Operating Income (EBIT) | ($406M) | ($385M) | ($252M) | ($171M) | ($134M) | ($130M) | ($87M) | ($55M) | ($51M) | ($25M) | ($16M) |
| Operating Margin % | — | — | — | — | -404.8% | -690.5% | -564.0% | -266.2% | — | — | -4277.0% |
| Net Income | ($409M) | ($378M) | ($246M) | ($166M) | ($132M) | ($132M) | ($85M) | ($50M) | ($49M) | ($25M) | ($16M) |
| Net Margin % | — | — | — | — | -396.6% | -700.5% | -551.8% | -242.5% | — | — | -4276.2% |
| EBITDA | ($396M) | ($369M) | ($238M) | ($163M) | ($131M) | ($129M) | ($85M) | ($53M) | ($50M) | ($24M) | ($16M) |
| Earnings Per Share (EPS) | $-3.36 | $-3.29 | $-2.47 | $-2.18 | $-2.21 | $-3.59 | $-2.77 | $-1.80 | $-3.15 | $-1.40 | $-0.91 |
| Shares Outstanding (M) | 131M | 115M | 100M | 76M | 60M | 37M | 31M | 28M | 16M | 18M | 18M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | ($47M) | ($50M) | $0M | ($49M) | $0M | $0M |
| Gross Margin % | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($109M) | ($102M) | ($92M) | ($104M) | ($112M) | ($77M) | ($69M) | ($65M) |
| Operating Margin % | — | — | — | — | — | — | — | — |
| Net Income | ($110M) | ($106M) | ($91M) | ($102M) | ($110M) | ($75M) | ($66M) | ($64M) |
| Net Margin % | — | — | — | — | — | — | — | — |
| EBITDA | ($105M) | ($103M) | ($88M) | ($100M) | ($108M) | ($74M) | ($66M) | ($64M) |
| Earnings Per Share (EPS) | $-0.84 | $-0.83 | $-0.79 | $-0.90 | $-0.98 | $-0.67 | $-0.67 | $-0.66 |
| Shares Outstanding (M) | 131M | 127M | 115M | 114M | 113M | 112M | 100M | 97M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($296M) | ($300M) | ($201M) | ($145M) | ($133M) | ($127M) | ($60M) | ($63M) | $25M | ($22M) | ($15M) |
| Capital Expenditures (CapEx) | $0M | $1M | $0M | $0M | $1M | $5M | $4M | $3M | $1M | $0M | $1M |
| Free Cash Flow (FCF) | ($296M) | ($301M) | ($201M) | ($145M) | ($134M) | ($132M) | ($64M) | ($66M) | $23M | ($22M) | ($16M) |
| FCF Margin % | — | — | — | — | -403.0% | -701.7% | -417.8% | -323.2% | — | — | -4204.5% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($70M) | ($82M) | ($75M) | ($69M) | ($77M) | ($79M) | ($50M) | ($52M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($70M) | ($82M) | ($76M) | ($69M) | ($77M) | ($79M) | ($50M) | ($52M) |
| FCF Margin % | — | — | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $524M | $404M | $475M | $311M | $358M | $304M | $388M | $196M | $181M | $62M | $33M |
| Cash & Cash Equivalents | $437M | $324M | $178M | $102M | $103M | $213M | $160M | $36M | $115M | $56M | $10M |
| Total Liabilities | $270M | $159M | $106M | $86M | $98M | $132M | $128M | $83M | $75M | $115M | $63M |
| Total Debt (Short + Long-Term) | $203M | $105M | $56M | $57M | $58M | $65M | $30M | $1M | $0M | $1M | $2M |
| Total Shareholders' Equity | $254M | $245M | $369M | $225M | $260M | $172M | $261M | $113M | $107M | ($54M) | ($30M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SRRK viewer.
About TickerBase · Data methodology & sources · Privacy · Terms